227 related articles for article (PubMed ID: 22959996)
1. Gliomas and seizures.
Prakash O; Lukiw WJ; Peruzzi F; Reiss K; Musto AE
Med Hypotheses; 2012 Nov; 79(5):622-6. PubMed ID: 22959996
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and morphological risk factors for epilepsy in patients with glial and metastatic brain tumors].
Prokudin MY; Odinak MM; Litvinenko IV; Martynov BV; Svistov DV; Bushurov SE; Klitsenko OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):22-28. PubMed ID: 33340293
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract][Full Text] [Related]
4. Seizure characteristics and prognostic factors of gliomas.
Kerkhof M; Vecht CJ
Epilepsia; 2013 Dec; 54 Suppl 9():12-7. PubMed ID: 24328866
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and treatment of seizures in patients with high-grade glioma: a review.
Englot DJ; Berger MS; Chang EF; Garcia PA
Neurosurg Clin N Am; 2012 Apr; 23(2):227-35, vii-viii. PubMed ID: 22440866
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna].
Oberndorfer S; Schmal T; Lahrmann H; Urbanits S; Lindner K; Grisold W
Wien Klin Wochenschr; 2002 Nov; 114(21-22):911-6. PubMed ID: 12528323
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
9. A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG).
Rades D; Witteler J; Olbrich D; Trillenberg P; Schild SE; Tvilsted S; Kjaer TW
BMC Cancer; 2021 Apr; 21(1):386. PubMed ID: 33836671
[TBL] [Abstract][Full Text] [Related]
10. Epilepsy in cerebral glioma: timing of appearance and histological correlations.
Rosati A; Tomassini A; Pollo B; Ambrosi C; Schwarz A; Padovani A; Bonetti B
J Neurooncol; 2009 Jul; 93(3):395-400. PubMed ID: 19183850
[TBL] [Abstract][Full Text] [Related]
11. Pathologic analysis of primary brain tumors.
McComb RD; Burger PC
Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
13. Seizures in glioma patients: An overview of incidence, etiology, and therapies.
Samudra N; Zacharias T; Plitt A; Lega B; Pan E
J Neurol Sci; 2019 Sep; 404():80-85. PubMed ID: 31352293
[TBL] [Abstract][Full Text] [Related]
14. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
15. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
[TBL] [Abstract][Full Text] [Related]
16. Extent of Resection and Residual Tumor Thresholds for Postoperative Total Seizure Freedom in Epileptic Adult Patients Harboring a Supratentorial Diffuse Low-Grade Glioma.
Still MEH; Roux A; Huberfeld G; Bauchet L; Baron MH; Fontaine D; Blonski M; Mandonnet E; Guillevin R; Guyotat J; Taillandier L; Capelle L; Duffau H; Pallud J
Neurosurgery; 2019 Aug; 85(2):E332-E340. PubMed ID: 30395304
[TBL] [Abstract][Full Text] [Related]
17. Seizures and gliomas--towards a single therapeutic approach.
Huberfeld G; Vecht CJ
Nat Rev Neurol; 2016 Apr; 12(4):204-16. PubMed ID: 26965673
[TBL] [Abstract][Full Text] [Related]
18. The role of neurotransmitters in glioblastoma multiforme-associated seizures.
Joghataei MT; Bakhtiarzadeh F; Dehghan S; Ketabforoush AHME; Golab F; Zarbakhsh S; Ahmadirad N
Int J Dev Neurosci; 2023 Dec; 83(8):677-690. PubMed ID: 37563091
[TBL] [Abstract][Full Text] [Related]
19. Significance of chronic epilepsy in glial tumors and correlation with surgical strategies.
Kim OJ; Yong Ahn J; Chung YS; Chung SS; Lee KS; Choi JU; Lee BI
J Clin Neurosci; 2004 Sep; 11(7):702-5. PubMed ID: 15337128
[TBL] [Abstract][Full Text] [Related]
20. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.
Yang Y; Mao Q; Wang X; Liu Y; Mao Y; Zhou Q; Luo J
J Clin Neurosci; 2016 Sep; 31():56-62. PubMed ID: 27406953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
